That might sound like a stupid question. I mean, there’s a package right there in the refrigerator that says “hummus” on it. That guy from Arrested Development tells me it’s real hummus. If this country can allow defamation suits over suggesting that “pink slime” is not “ground beef,” why would anyone think to look further than face value on a foodstuff’s name?
But when it comes to hummus — a product that’s spurred legal battles before — the FDA is being dragged into the debate over what it really means to be a vegan’s replacement for protein delightful Mediterranean dip….
Despite the ever-growing ways that the U.S. Food and Drug Administration regulates what Americans can consume, FDA does not currently regulate genetically modified food. The State of Vermont wants to step in.
This week, Vermont will become the first state to mandate labeling of food products containing ingredients from genetically modified organisms (GMOs). It would require retailers of raw agricultural commodities to clearly and conspicuously label GMO-sourced food with the words “produced with genetic engineering.” (Think ears of corn in your supermarket’s produce section.) Producers of packaged food products must label their products with similar language if any ingredient contained in the product comes from a genetically modified source. (Think of that 56-ingredient protein bar sitting on your desk.)
Why are some people so lathered up about eating ingredients that come from genetically modified crops? “Monsanto” has become a dirty word, with nouveau-hippie parents washing out their kids’ mouths with biodegradable, SLS-free soap when they hear them say it. Unfortunately, much public debate conflates genetic modification, exposure to pesticides, and all sorts of other “unnatural” stuff related to food.
Ironically, genetic modification of seeds aims to make crops more resistant to pests, disease, and drought, thus reducing the need for conventional chemical pesticides and increasing crop yields. A growing world population demands innovation to produce more crops with fewer resources. Billions of people need to eat. Too many GMO opponents seem to picture Dr. Frankenstein when they should be picturing Gregor Mendel or Mother Teresa. (Or, to be fair, Walter De Jong.)
That, however, is only the beginning of what’s foolish about Vermont’s new law . . . .
The U.S. Food and Drug Administration recently proposed new rules targeting electronic cigarettes. By its authority under the Food, Drug, and Cosmetic Act and the Family Smoking Prevention and Tobacco Control Act, FDA now regulates “tobacco products” — cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless tobacco. The proposed regulation would “deem” additional products within the scope of the statutory definition of “tobacco product.” FDA would deem electronic cigarettes to be tobacco products, even though e-cigs don’t contain tobacco leaves. The deeming regulation would give FDA the power to govern e-cigs’ manufacture, sale, and use, implementing age restrictions, mandating additional scientific review of products, and scrutinizing claims made by the makers of e-cigs.
The new regulations would prevent e-cigarette manufacturers from telling consumers that their products are a safer alternative than tobacco cigarettes. The deeming regulations would prohibit claiming that vaporized nicotine “presents a lower risk of tobacco-related disease or is less harmful than one or more commercially marketed tobacco products.” In fact, the new rules would prevent them from even advertising to the public that their “product or its smoke does not contain or is free of a substance,” even though e-cigs do not produce smoke and do not contain tobacco in any common-sense meaning of the word.
Banning this sort of claims is absurd: e-cigs lack the more than 4,000 chemicals, many of them carcinogenic, of combustible tobacco cigarettes. Electronic nicotine vaporizers need not be particularly healthy in order to be less unhealthy than traditional cigarettes.
This regulatory push is poisoned by a bevy of bad arguments. Most of the rhetoric consists of pure emotion on the part of anti-tobacco activists. Certain anti-tobacco and anti-smoking factions grow hysterical at the mere specter of smoking. Unfortunately, a more powerful lobby is also trying to squelch e-cigs . . . .
I guess soda pushers will have to go back to slinging rocks.
In case you haven’t been following along with developments inside Mike Bloomberg’s militarized nanny state, last year our elected tyrant outlawed the sale of soda in sizes over 16 ounces at movie theaters and other public places. The mayor felt that nobody needed more than 16 ounces of soda in one sitting, notwithstanding the fact that nobody asked him what my mother thinks.
There are only three occasions on which I order a Budweiser:
I haven’t decided what beer I want when it’s my turn to order and I say, “I’ll start with a Bud,” because I don’t want to stare at the waitress with my mouth hanging open like this is my first rodeo.
I haven’t decided if I want to get drunk with that person or group, so I order a Bud in a non-committal fashion that indicates, “I might have a pitcher of this, or I might leave a half drunk one on the table and bail. At the very least, I’ll be going to the bathroom soon to reassess.”
I’m at a sporting event, concert, kegger, or involved in a drinking game. Anything that says “it’s about the quantity not the quality.”
Absent those (more specific than you think) circumstances, I don’t drink Budweiser. Eww, gross, who does that? It tastes like nothing, goes through you like bullet, and says “I like TV commercials” to the general public.
But last week, Anheuser-Busch InBev got sued because a plaintiff alleges that the Buds (and other beers brewed by the company) have been purposefully watered down.
And here I thought that disreputable bars watered down their real beer with Bud Lights….
Ed. note: The Asia Chronicles column is authored by Kinney Recruiting. Kinney has made more placements of U.S. associates, counsels and partners in Asia than any other recruiting firm in each of the past seven years. You can reach them by email: firstname.lastname@example.org.
It’s that time of year again when JDs are starting to apply for 2L summer jobs and 2L summers are deciding which practice area to focus on.
For those JDs with an interest in potentially lateraling to or transferring to Asia in the future, please feel free to reach out to Kinney for advice on firm choices, interviewing and practice choices, relating to future marketability in Asia, or for a general discussion on your particular Asia markets of interest. This is of course a free of cost service for those who some years in the future may be our future industry contacts or perhaps even clients.
For some years now Kinney’s Asia head, Evan Jowers, has been formally advising Harvard Law students with such questions, as the Asia expert in Harvard Law’s “Ask The Experts Market Program” each summer and fall, with podcasts and scheduled phone calls. This has been an enjoyable and productive experience for all involved.
Whether you’re fresh off the bar exam or hitting your stride after hanging a shingle a few years ago, one thing’s for certain: independent attorneys who start a solo or small-law practice live with a certain amount of stress.
Non-attorneys would think the stress comes from preparing for a big trial, deposing a hostile witness, or crafting the perfect contract for a picky client.
But that’s nothing compared to the constant, nagging, real-life kind, the kind you get from the day-to-day grind of being a law-abiding attorney.
Connecticut plaintiffs-side boutique litigation firm (12 lawyers) seeks full-time associate with 2-4 years litigation experience, top tier undergraduate and law school education. Journal or clerkship experience a plus; highest ethical standards and strong work ethic required. Familiarity with Connecticut state court legal practice is preferred, but not required.
The firm handles sophisticated, high-end cases for plaintiffs, including individuals and businesses with significant claims in a wide array of matters. Our cases often have important public policy implications, and are litigated in state and federal courts throughout Connecticut. Representative areas of practice include medical malpractice, catastrophic personal injury, business torts, deceptive trade practices and other complex commercial litigation, and products liability.
Additional information can be located on our website, at www.sgtlaw.com.